Medical Marijuana, Inc. Subsidiary HempMeds Welcomes UFC Champion Raoni Barcelos as Brand Spokesperson

San Diego, CA - (NewMediaWire) - June 24, 2021 - Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s subsidiary HempMeds® is excited to welcome five-time Brazilian national wrestling champion and professional UFC fighter Raoni Barcelos as its newest spokesperson for the company.

Barcelos, who hails from Rio De Janeiro, is a former amateur wrestler and grappler, and current professional mixed martial artist (MMA). Barcelos has been an active fighter for nine years in the bantamweight division.

“We are excited to begin this new project and begin partnering worldwide with professional athletes who may be able to improve their wellness by taking our products,” said HempMeds® CEO Raul Elizalde. “We feel that his testimony will help the public learn about their potential benefits.”

In addition to his titles in Brazil, Barcelos is also a two-time South-American Wrestling Champion and was featured at the “Fight of the Night” twice with the UFC. Barcelos is also a three-time Resurrection Fighting Alliance Featherweight Champion. In his MMA career, he’s won 16 fights with 8 knockouts.

“I have been using HempMeds’ CBD products to aid in recovery after long days of training and grueling fight schedules,” said Barcelos. “I hope to share knowledge with athletes around the world who could benefit from using CBD but are afraid to use the products or uninformed of how to use them.” 

Fans can watch Barcelos fight Timur Valiev on Saturday, June 26, 2021, during UFC Fight Night: Gane vs. Volkov.

To learn more about HempMeds®, please visit the Company online at www.hempmedspx.com.

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix.  Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:
Kathryn Brown
Account Director
CMW Media
P. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com